Your Global Leader in Stem Cell Market Research
BioInformant's coverage of stem cell news includes iPS cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells and more.
As the first and only market research firm to specialize in stem cell news, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine.
Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry news.
WARSAW, Poland, Aug. 31, 2021 — Polski Bank Komórek Macierzystych S.A. (PBKM), which leads the international FamiCord Group, Europe’s largest stem cell bank, signed a transaction agreement with shareholders of Smart Cells Holdings Limited, based in London UK. [Read more…]
IRVINE, CALIFORNIA, USA, August 10, 2021 — HealthBanks Biotech, Inc. (“HealthBanks” or the “Company”), a premium U.S. stem cell and immune cell bank headquartered in Irvine, CA, today announces the launch of its newest cord blood banking membership plans and prices. [Read more…]
DRESDEN, Germany, August. 11, 2021 /BioInformant/ — denovoMATRIX GmbH, a leading developer of technologies which enable high quality stem cell expansion, today announced the publication of patent application US2021/0145980, titled ‘non-covalently assembled matrix layer’. The patent is expected to provide broad protection for denovoMATRIX’ proprietary screenMATRIX and myMATRIX product lines in the Unites States. [Read more…]
NASHVILLE, TN, July 22, 2021 — EV Biologics (OTC PINK:YECO) announced that it has signed a Letter of Intent (LOI) with Lonza Cell & Gene Therapy for Process Development and Gap Analysis for biomanufacturing of a novel therapeutic composition, comprising extracellular vesicles (EVs) and particles, as well as other secreted factors derived from selected stem/progenitor cells, such as mesenchymal stromal cells (MSCs). [Read more…]
